@article{5e63fc592cad4527bb10b12c542b6da9,
title = "A phase II study of combination chemotherapy in early relapsed epithelial ovarian cancer using gemcitabine and pegylated liposomal doxorubicin",
abstract = "Treatment of epithelial ovarian cancer patients relapsing with a short treatment-free interval (TFI) after prior chemotherapy is unsatisfactory. This phase II trial evaluated the activity and feasibility of pegylated liposomal doxorubicin (PLD) plus gemcitabine in this setting.",
keywords = "Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Cystadenocarcinoma, Serous, Deoxycytidine, Disease-Free Survival, Dose-Response Relationship, Drug, Doxorubicin, Female, Humans, Middle Aged, Ovarian Neoplasms, Polyethylene Glycols, Survival Rate",
author = "Mirza, {Mansoor Raza} and Bente Lund and Lindegaard, {Jacob Christian} and Nina Keldsen and Anders Mellemgaard and Christensen, {Ren{\'e} Depont} and Kamma Bertelsen",
note = "Copyright {\textcopyright} 2010 Elsevier Inc. All rights reserved.",
year = "2010",
month = oct,
day = "1",
doi = "10.1016/j.ygyno.2010.06.022",
language = "English",
volume = "119",
pages = "26--31",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press",
}